http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107118268-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43504 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
filingDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107118268-B |
titleOfInvention | Application of recombinant crassostrea gigas CgC1qDC-3 protein |
abstract | The invention belongs to the field of marine animal functional genes and immunocompetent proteins, and particularly relates to a recombinant crassostrea gigas CgC1qDC-3 protein and preparation and application thereof. The amino acid sequence of the recombinant protein is shown as SEQ ID N0.1. The recombinant CgC1qDC-3 protein is applied to preparation of a high-affinity medicament for specifically recognizing Lipopolysaccharide (LPS). The recombinant CgC1qDC-3 protein can specifically identify the Lipopolysaccharide (LPS) of a pathogen-related molecular pattern of gram-negative bacteria, and has strong binding affinity (equilibrium dissociation constant K) to the LPS D =8.74×10 ‑7 M). The recombinant protein obtained by the invention can be used for pathogenic bacteria recognition or the research and development of Lipopolysaccharide (LPS) competitive binding preparations. |
priorityDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.